ArticleFrontiers in oncology2025
Surgeon's perceptions on 3D visualization methods in parotid gland tumor surgery.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Recent advances in high-resolution MRI and reconstruction techniques offer new opportunities to enhance visualization of the facial nerve and its relationship to parotid tumors in 3D models. The aim of this study is twofold: first, to assess the technical feasibility of generating three-dimensional printed anatomical models from MRI data. Second, to evaluate surgeons' perceptions of three different visualization methods (3D models on a 2D screen, 3D-printed models, and augmented reality (AR) holograms) to identify the most advantageous method for surgeons performing parotid gland tumor surgery. Methods: Fifteen surgeons (otolaryngologists, cranio-maxillofacial, and head and neck) evaluated four clinical Cases using all three visualization methods, in addition to conventional MRI. Participants completed structured questionnaires assessing anatomical clarity, clinical utility, and perceived usefulness and ease of use. Statistical analyses included Friedman and Wilcoxon signed-rank tests, as well as Spearman correlations. Results: AR holograms achieved the highest median scores for tumor visibility, while all methods performed equally on anatomical landmark visibility. Significant differences in surgical decision-making were observed across cases, with 3D visualizations influencing preferences for surgical approach and perceived risk of facial nerve injury. For intended use, screen-based 3D models and conventional MRI were rated highest for patient consultation and preoperative planning, while intraoperative use received lower scores overall. Perceived usefulness and perceived ease of use scores were highest for AR and 2D screen models. The 3D-printed models were generally rated lower, though some value was noted for patient communication. Conclusion: Printing the facial nerve in relation to a tumor is feasible, despite technical challenges, for which solutions are provided. For clinical care, an anticipated role in preoperative patient consultation and surgical planning of 3D models was favored more than intraoperative use. Among the visualization methods, 3D-printed models were perceived as less effective than those displayed on a 2D screen or in AR. 3D models can serve as valuable adjuncts, but they do not replace conventional MRI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.